Patents by Inventor Michael F. Bradley

Michael F. Bradley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF A CYCLIN-DEPENDENT KINASE INHIBITOR
    Publication number: 20220259195
    Abstract: Provided herein are crystalline forms of a cyclin-dependent kinases (CDK) inhibitor, compositions thereof, methods of preparation thereof, and methods of use thereof.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 18, 2022
    Inventors: Matthew John BIGERT, Michael F. BRADLEY, Thomas Stearns TEMPLEMAN, Robert M. WENSLOW
  • Salt and crystalline forms thereof of a drug
    Patent number: 10329276
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: June 25, 2019
    Assignee: ABBVIE INC.
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
    Publication number: 20180105510
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: December 18, 2017
    Publication date: April 19, 2018
    Inventors: Geoff G.Z. ZHANG, Michael F. BRADLEY, David M. BARNES, Rodger HENRY
  • Salt and crystalline forms thereof of a drug
    Patent number: 9873681
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 23, 2018
    Assignee: ABBVIE INC.
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
    Publication number: 20170073329
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Inventors: Geoff G.Z. ZHANG, Michael F. BRADLEY, David M. BARNES, Rodger HENRY
  • Salt and crystalline forms thereof of a drug
    Patent number: 9539250
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: January 10, 2017
    Assignee: ABBVIE INC.
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Salt and Crystalline Forms Thereof of a Drug
    Publication number: 20150196547
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: February 3, 2015
    Publication date: July 16, 2015
    Inventors: Geoff G.Z. ZHANG, Michael F. BRADLEY, David M. BARNES, Rodger HENRY
  • Salt and crystalline forms thereof of a drug
    Patent number: 8969569
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: March 3, 2015
    Assignee: AbbVie Inc.
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
    Patent number: 8841455
    Abstract: Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: September 23, 2014
    Assignee: Array BioPharma Inc.
    Inventors: Mark Laurence Boys, Michael F. Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy, Fredrik P. Marmsater, Matthew David Medina, Mark C. Munson, Bryson Rast, James P. Rizzi, Martha E. Rodriguez, George T. Topalov, Qian Zhao
  • Salt and Crystalline Forms Thereof of a Drug
    Publication number: 20140155380
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: February 7, 2014
    Publication date: June 5, 2014
    Applicant: ABBVIE INC.
    Inventors: Geoff G.Z. ZHANG, Michael F. BRADLEY, David M. BARNES, Rodger HENRY
  • Salt and crystalline forms thereof of a drug
    Patent number: 8648093
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: February 11, 2014
    Assignee: Abbvie Inc.
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Salt and Crystalline Forms Thereof of a Drug
    Publication number: 20130060040
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: August 27, 2012
    Publication date: March 7, 2013
    Applicant: ABBOTT LABORATORIES
    Inventors: Geoff G.Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
    Publication number: 20120258952
    Abstract: Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
    Type: Application
    Filed: December 20, 2010
    Publication date: October 11, 2012
    Applicant: ARRAY BIOPHARMA INC.
    Inventors: Mark Laurence Boys, Michael F. Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy, Fredrik P. Marmsater, Matthew David Medina, Mark C. Munson, Bryson Rast, James P. Rizzi, Martha E. Rodriguez, George T. Topalov, Qian Zhao
  • Salt and crystalline forms thereof of a drug
    Patent number: 8273892
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: September 25, 2012
    Assignee: Abbott Laboratories
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Salt and crystalline forms thereof of a drug
    Patent number: 8252813
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: August 28, 2012
    Assignee: Abbott Laboratories
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
    Publication number: 20100286397
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: April 20, 2010
    Publication date: November 11, 2010
    Inventors: Geoff G.Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
    Publication number: 20100261703
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Application
    Filed: February 5, 2010
    Publication date: October 14, 2010
    Applicant: Abbott Laboratories
    Inventors: Geoff G.Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Salt and crystalline forms thereof of a drug
    Patent number: 7728143
    Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: June 1, 2010
    Assignee: Abbott Laboratories
    Inventors: Geoff G. Z. Zhang, Michael F. Bradley, David M. Barnes, Rodger Henry
  • Ureas having antiangiogenic activity
    Patent number: 7592466
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: September 22, 2009
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley, Daryl R. Sauer
  • Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
    Patent number: 7169888
    Abstract: Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: January 30, 2007
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley